OPT
Click for more information
1.39% 35.5¢ opthea limited

CATT of course tested ranibizumab (Lucentis) as the control...

  1. PigRace
    101 Posts.
    lightbulb Created with Sketch. 84
    clock Created with Sketch.
    11/05/24
    22:06
    Post #: 73781218
    CATT of course tested ranibizumab (Lucentis) as the control against bevacizumab (Avastin) and not aflibercept (Eylea) against bevacizumab (Lucentis).

    Apologies. I was too late to edit my above post.
    OPT Price at posting: 68.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
CC9 Chariot Corporation marches forward with discovery-level drill program in Wyoming, USA
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
35.5¢ 		Change
-0.005(1.39%) 		Mkt cap ! $387.4M
Open High Low Value Volume
36.0¢ 36.0¢ 35.5¢ $632.4K 1.766M

Buyers (Bids)

No. Vol. Price($)
11 361309 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 38071 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.